TNFRSF9 and neoplasm: Similar studies have demonstrated the role of the secondary co-stimulatory molecule 4-1BB (CD137) in enhancing mitochondrial biogenesis and in improving tumor control when synergistically used with PD-1 blockade (a co-inhibitory molecule) [17].